{{Rsnum
|rsid=10922153
|Gene=CFHR5
|Chromosome=1
|position=197009485
|Orientation=plus
|GMAF=0.3173
|Gene_s=CFHR5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 25.0 | 56.2 | 18.8
| HCB | 0.7 | 25.2 | 74.1
| JPT | 1.8 | 26.5 | 71.7
| YRI | 0.0 | 23.6 | 76.4
| ASW | 8.9 | 26.8 | 64.3
| CHB | 0.7 | 25.2 | 74.1
| CHD | 0.9 | 16.5 | 82.6
| GIH | 11.1 | 44.4 | 44.4
| LWK | 2.7 | 25.5 | 71.8
| MEX | 15.5 | 43.1 | 41.4
| MKK | 3.8 | 25.0 | 71.2
| TSI | 20.2 | 52.5 | 27.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23582991
|Title=Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration
}}

{{PMID Auto
|PMID=18541031
|Title=The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration.
|OA=1
}}

{{PMID Auto
|PMID=19801603
|Title=Rapid inexpensive genome-wide association using pooled whole blood.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}